Myalept (Aegerion Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Myalept drug offered from Aegerion Pharmaceuticals, Inc.. This Leptin Analog [EPC],Analogs/Derivatives [Chemical/Ingredient],Leptin [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Aegerion Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | metreleptin |
SUBSTANCE NAME: | METRELEPTIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Leptin Analog [EPC],Analogs/Derivatives [Chemical/Ingredient],Leptin [Chemical/Ingredient] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2015-03-05 |
END MARKETING DATE: | 0000-00-00 |
Myalept HUMAN PRESCRIPTION DRUG Details:
Item Description | Myalept from Aegerion Pharmaceuticals, Inc. |
LABELER NAME: | Aegerion Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 11.3(mg/2.2mL) |
START MARKETING DATE: | 2015-03-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76431-210_82a9c700-28e5-4d9b-80e7-c343ba5da1fc |
PRODUCT NDC: | 76431-210 |
APPLICATION NUMBER: | BLA125390 |
Other METRELEPTIN Pharmaceutical Manufacturers / Labelers: